Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Fidarestat reverses cellular responses to high glucose concentrations

May 22, 2002

Merck discovers new antidiabetic PPAR agonists

May 22, 2002

New cholesterol-lowering agents in development at Ilex Oncology

May 22, 2002

Novel antiobesity agents presented by Sanofi-Synthelabo

May 22, 2002

Cardiome acquires Oxyprim data

May 21, 2002

Vitamin D3 analogue arrests development of autoimmune diabetes

May 21, 2002

Actonel 35 mg approved for once-weekly dosing in postmenopausal osteoporosis

May 21, 2002

Diabetic fruit flies may provide new information on the development of human pancreatic beta-cells

May 17, 2002

AndroGel approved in Canada for testosterone insufficiency

May 16, 2002

Late-stage clinical trial results for new osteoporosis therapy discussed in Lisbon

May 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...